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Background: Portal vein embolization (PVE) is employed to increase future remnant liver
(FRL) volume through induction of hepatocellular regeneration in the nonembolized liver
lobe. The regenerative response is commonly determined by CT volumetry after PVE. The
aim of the study was to examine plasma bile salts and triglycerides in the prediction of the
regenerative response following PVE.
Methods: PVE of the cranial liver lobe was performed in 15 rabbits, divided into three groups:
NaCl (control), gelatin sponge (short-term occlusion), and polyvinyl alcohol particles with
coils (PVAc, long-term occlusion). In all rabbits CT volumetry and blood sampling were
performed prior to PVE and on days 3 and 7. Plasma bile salts and triglycerides were
correlated with volume increase of the nonembolized liver lobe.
Results: After 3 and 7 d, respectively, FRL volume was increased in both embolized groups,
with the largest hypertrophy response observed in the PVAc group. Plasma bile salt levels
were increased after PVE, especially in the PVAc group at day 3 (P < 0.01 compared to
gelatin sponge). Plasma bile salts at day 3 predicted FRL volume increase at day 7 showing
a positive correlation of 0.811 (P < 0.001). Levels of triglycerides were not significantly
altered in either of the PVE procedures.
Conclusions: Plasma bile salt levels early after PVE strongly correlated with the regenerative
response in a rabbit model of PVE, showing more pronounced elevation with larger volume
increase of the nonembolized lobe. Therefore, plasma bile salts, but not triglycerides, can
be used in the prediction of the regenerative response after PVE.
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increase the size and function of the future remnant liver (FRL)
preoperatively [1,2].
One way to increase the FRL in unresectable patients is
portal vein embolization (PVE) of the lobe to be resected. PVE
was first described in 1986 in Japan by Kinoshita [3]. Today,
PVE is increasingly used in the preoperative management of
patients proposed for liver resection in whom FRL volume is
deemed insufficient. The usual method to assess liver hyper-
trophy in the nonembolized lobe following PVE is CT volu-
metry, performed 3e6 wk after PVE. A drawback of PVE is
concomitant enhancement of tumor growth as a result of the
release of regenerative factors after PVE. Prediction of effec-
tive hypertrophy at an earlier time point is therefore desirable,
in order to minimize the waiting time between PVE and
subsequent liver resection.
An experimental study by Huang et al. [4] showed increased
serum bile salt levels during regeneration following partial
hepatectomy in mice. In addition, this study showed that an
elevation in serum bile salt levels accelerated liver regenera-
tion, whereas a decrease in serum bile salts inhibited liver
regrowth after partial liver resection [4]. The latter effect was
confirmed in rat studies by Ueda et al. [5] and Dong et al. [6].
Another study demonstrated increased bile salt levels within
the nonligated lobes after portal vein ligation in rats [7].
Subsequently, Hayashi et al. [8] showed a significant relation
between increased bile salt levels and the degree of hyper-
trophy in the nonembolized lobe in humans [8]. Apart from
these studies, little is known about the relation between bile
salts, PVE, and the hypertrophy response of the liver.
In addition to the existence of a relation between liver
regeneration and bile salts [9e11], triglycerides also accumulate
during liver regeneration. Previous studies have shown that
triglycerides accumulate in the rat liver 15e20 h after partial
hepatectomy [12,13]. Miyamura et al. also revealed an accu-
mulation of triglycerides in regeneratingmouse livers 24 h after
partial hepatectomy [14]. The precise role of bile salts and
triglycerides in liver hypertrophy and regeneration is still
unknown. The aim of this study, therefore, was to examine
plasma bile salts and triglycerides in the prediction of the
regenerative response following PVE in a rabbit model of PVE.2. Materials and methods
2.1. Animal study
Fifteen female New Zealand White rabbits (Harlan, Gannat,
France) with a mean weight of 3.0  0.5 kg were acclimatized
for 1 wk under standardized laboratory conditions in
a temperature-controlled room. The animals were individu-
ally housed, had free access to standard laboratory food and
water, and were subjected to a 12-h light/dark cycle per d.
Experimental protocols were approved by the Institutional
Animal Ethics Committee.
2.2. Experimental design
The rabbit liver consists of four liver lobes, three of which
are positioned cranially, with the fourth located caudally[15]. In our rabbit PVE model the cranial liver lobes, which
account for approximately 80% of the total liver volume,
were embolized. The rabbits were divided into a control
group receiving NaCl (n ¼ 5) and two groups in which the
portal vein to the cranial liver lobes was embolized by either
liquefied gelatin sponge (short-term occlusion; n ¼ 5) or
polyvinyl alcohol particles and coils (PVAc, long-term
occlusion; n ¼ 5). The rabbit was placed in a supine posi-
tion after subcutaneous injection of 0.03 mg/kg buprenor-
phine (Temgesic; Reckitt Benckiser Healthcare Limited,
Hull, UK) and 0.02 mg/kg enrofloxacin (Baytril; Bayer
Healthcare, Berlin, Germany). Rabbits were given enro-
floxacin 0.02 mg/kg subcutaneously once a day for 3 d
postoperatively. Animals were anesthetized by intramus-
cular injection of 25.0 mg/kg ketamine (Nimatek; Eurovet,
Bladel, The Netherlands) and 0.2 mg/kg dexmedetomidine
(Dexdomitor; Orion Corporation, Espoo, Finland). Isoflurane
1%e2% (Forene; Abbott Laboratories, Kent, UK) with O2/air
(1:0.7 L/min) was used to maintain anesthesia. Heart rate
and arterial oxygen saturation were measured by pulse
oximetry (Hewlett Packard M1165A model 56S; Hewlett
Packard, Andover, MA) continuously throughout the
procedure.
To identify the individual portal branches, a portography
was made. After passing the portal branch to the caudal liver
lobe, a microcatheter was positioned into the main portal
branch supplying the cranial liver lobes. Control animals
received 2.0mL NaCl via themicrocatheter. In the short-term
occlusion group, liquefied gelatin sponge (Spongostan;
Ferrosan, Soeborg, Denmark) was delivered until flow ceased.
Animals in the long-term occlusion group received an initial
mixture of contrast (Visipaque; GE Healthcare, Waukesha,
WI) and 90e180 mm PVA particles (Cook, Bloomington, IN),
followed by injection of 300e500 mm PVA particles until
cessation of flow and placement of three platinum coils
(6 mm, Tornado Embolization Microcoil; Cook, Bloomington,
IN). All embolizations were performed by an interventional
radiologist (K.P.vL.) with over 10 y experience. Further details
of the embolization technique have been described else-
where [16].
Portography directly after PVE confirmed total occlusion
of the cranial portal blood flow in the embolization groups.
The hypertrophy response of the caudal lobe was measured
using CT volumetry before embolization and on day 3 and 7
postembolization. Serum bile salt and triglyceride levels
were determined at baseline, at 3 h, and at days 1, 3, and 7
after PVE.
2.3. Liver volume
Multiphase contrast-enhanced CT scans were carried out in
rabbits using the multislice helical scanner (Philips Medical
Systems, Eindhoven, The Netherlands). Total liver, tumor, and
FRL were delineated manually, after which the total liver
volume (TLV), tumor volume (TV), and FRL volume (FRLV)
were calculated with integrated software (Mx-View 3$52;
Philips Medical Systems). The percentage of FRL was then
calculated by the following formula: %FRL ¼ (FRLV  100%)/
(TLV TV). A detailed description of CT volumetry in rabbits is
described elsewhere [16].
Fig. 1 e Portal vein embolization induces liver hypertrophy
in rabbits. FRL volume was determined by CT volumetry
prior to and after embolization of the cranial portal vein
with gelatin sponge (solid squares, short-term occlusion) or
PVAc (solid triangles, long-term occlusion). There was no
change in increase in FRL volume in the control group (solid
dots), whereas increased FRL volume was apparent at day 3
and day 7 in animals embolized with gelatin sponge or
PVAc. Data are expressed in mean ± SEM, * denotes
P< 0.05. (Color version of figure is available online.)
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In all blood samples, plasma aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) were assessed to
examine the degree of liver damage. Plasma bilirubin was
determined as indirect measure of hepatic function (hepatic
uptake and excretory function). Serum levels of triglycerides
were also evaluated to examine liver regeneration. All above-Fig. 2 e Liver damage following PVE. Plasma AST (A) and
ALT (B) exhibited a transient increase with a peak
concentration on day 1 (*P< 0.05). (Color version of figure
is available online.)mentioned parameters were determined by routine clinical
chemistry. Total serum bile salts were assayed by an enzy-
matic method as per manufacturer’s instructions (Diazyme
Laboratories, Poway, CA).
2.5. Statistical analysis
Statistical analysis was performed with Statistical Package for
Social Sciences (SPSS 18.0; SPSS, Chicago, Illinois) and
GraphPad Prism (GraphPad Software, San Diego, CA). CT
volumetry data were compared using a mixed-model analysis
based on ranked data. Continuous nonparametric data were
compared by the Mann-Whitney U test. The Wilcoxon signed
rank test was used for nonparametric continuous data for
different time points within groups. Correlation between
variables was tested using the Pearson r correlation coeffi-
cient. All statistical tests were 2-tailed and differences were
considered significant at a P value of 0.05. Data were
expressed as means  SD, unless stated otherwise.3. Results
3.1. Embolization with PVA particles and coils induces
a strong hypertrophy response in rabbits
The PVE procedure was performed successfully in all rabbits.
Before embolization, FRL volume, expressed as a percentageFig. 3 e Serumbile salts are elevated following experimental
PVE. Bile salts (A), but not triglycerides (B), are elevated after
PVE and returned to baseline values within a week.
Statistically significant differences (P< 0.05) comparedwith
pre-PVE baseline values are indicated by an asterisk.
Mean ± SEM data are shown. (Color version of figure is
available online.)
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and 22.4%  1.2% for the control, gelatin sponge, and PVAc
groups, respectively, with a significant difference between the
control group and PVAc (P ¼ 0.009). As expected, %FRL
remained constant during the follow-up period in the control
group (Fig. 1). After 3 d, %FRL was increased in both embolized
groups, with the largest hypertrophy response in the PVAc
group. Further increase of %FRL at day 7 post-PVE was most
striking in the PVAc group, with a near-doubling of lobular
volume (80%) induced by PVE.
Both PVE procedures resulted in a transient elevation of
transaminases that peaked after the first day, with normali-
zation of transaminases after 3e7 d (Fig. 2A and B). Bilirubin
levels were not significantly altered at the respective time
points after PVE (data not shown).3.2. Bile saltsdbut not triglyceridesdare elevated
after PVE
Baseline bile salt levels were similar in the three groups, and
remained constant throughout the follow-up period in theFig. 4 e Bile salt levels at days 1 (A), 3 (B), and 7 (C) predict the inc
between bile salts and the increase of FRL on day 3. (Color verscontrol group (Fig. 3A). In contrast, a rapid increase in bile salt
levels was apparent already after 3 h in the gelatin sponge
group and levels remained elevated for at least 3 d before
gradual return to baseline levels. The profile of bile salt levels
in the PVAc group differed, peaking at a later time point (3 d)
while remaining elevated after 7 d. Unlike bile salts, levels of
triglycerides were not significantly changed by either of the
PVE procedures (Fig. 3B).3.3. Correlation of bile salts and triglycerides with FRL
volume
Correlation data of plasma bile salt levels and increase in %
FRL are shown in Figs. 4 and 5. Analysis of the pooled results of
all rabbits showed positive correlations of bile salt levels after
PVE, and %FRL or increase in %FRL on days 3 and 7 following
PVE. For triglycerides, no significant correlations were
observed with (increase of) %FRL (data not shown).
For the separate groups (NaCl, gelatin sponge, and PVAc),
no significant correlations between plasma AST or ALT levels
on day 1 and (increase in) %FRL were observed. Whenrease in %FRL at day 3 in rabbits. Correlations (r) are shown
ion of figure is available online.)
Fig. 5 e Significant correlations (r) are shown between bile salts on day 1 (A), day 3 (B), and day 7 (C) and the increase of FRL
on day 7. (Color version of figure is available online.)
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found between ALT on day 1 and %FRL on day 7 (r ¼ 0.530,
P ¼ 0.042), increase in %FRL on day 3 (r ¼ 0.526, P ¼ 0.044), and
increase in %FRL on day 7 (r ¼ 0.603, P¼ 0.017). For AST on day
1 a positive correlation was seen with the increase in %FRL on
day 7 (r ¼ 0.542, P ¼ 0.037).4. Discussion
Plasma bile salts and triglycerides were examined as predic-
tive factors for the regenerative response following PVE. An
established rabbit model of PVE was used [17e19] to study
possible correlations between plasma bile salt and triglyceride
levels and growth of FRL using two different embolization
agents: gelatin sponge and PVAc. This analysis showed that
plasma bile saltsdbut not triglyceridesdsignificantly pre-
dicted the hypertrophy response after PVE.To our knowledge, a predictive correlation between bile
salts and FRL growth has not been previously explored in an
animal model of PVE, while only a single study has addressed
this issue in patients [8]. Several experimental studies showed
an increase in serum bile salts or triglycerides during liver
regeneration after partial hepatectomy [4e6]. This is partly in
line with our observations. Bile salts increased significantly in
the rabbit model after PVE, suggesting that bile salt levels are
a useful predictor of effective hypertrophy of the non-
embolized liver lobe after PVE. However, we did not find
significant changes in serum triglyceride levels following PVE
in the rabbit PVE model, despite multiple studies reporting
a significant increase in serum and hepatic triglycerides
during the hypertrophy response [12,13]. The reason for the
absence of a significant increase in triglycerides following PVE
in our animal study could be 2-fold. First, most studies have
been performed in rat models, while we chose a rabbit model,
since this model is more compatible with the human situa-
tion; and the size of rats brings along surgical and technical
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more difficult, and introduction of the cannula in the portal
vein for embolization is challenging. Second, the above-
mentioned studies in literature were performed in combina-
tion with partial hepatectomy. Therefore, several pathways
were activated, resulting in a hypertrophy response of FRL
after liver resection, which could subsequently lead to
elevated triglyceride levels. Thus, whereas hepatectomy in
rats resulted in increased triglycerides, PVE in rabbits did not
affect serum triglyceride levels, suggesting different mecha-
nisms in the regenerative response after resection or PVE [20].
Serum bile salts are increased after PVE, especially upon
long-term embolization using PVA and coils (Fig. 3A). Plasma
bile salt levels at day 3 predicted FRL volume increase at day 7
with a positive correlation of 0.811. The increase in FRL
volume is most pronounced in the first week after PVE
measured by CT volumetry in a rabbitmodel with amaximum
hypertrophy response on day 7, although the volume increase
of FRL is greatest during the first 3 wk after PVE in humans.
Previous clinical studies showed considerable variation in
plasma bile salt levels prior to PVE, based on underlying liver
disease [8,21e23]. To compensate for these pre-embolization
variations, the increase of bile salt levels presumably is
a better way to predict FRL growth, as compared to absolute
bile salt values.
Our study has a limitation. The initial FRL in the control
group (26.3%  1.4%) was significantly different compared to
the PVAc group (22.4%  1.2%) in the rabbit PVE model,
although no interventions had been performed. As expected,
however, the increase in %FRL was significantly higher in the
PVAc group 7 d after PVE, and therefore did not seem to be
influenced by baseline values.
In conclusion, a positive correlation was found between
the increase in %FRL on day 3 and plasma bile salts in a rabbit
model of PVE. In rabbits with a greater hypertrophy response
after PVE, the increases in bile salts were also larger. Plasma
bile salts, therefore, show predictive value in the assessment
of the hypertrophy response after PVE.r e f e r e n c e s
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